Arindam K. Das
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arindam K. Das has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Busra Demir
TOBB University of Economics and Technology
1 shared publication - Caglanaz Akin Gultakti
TOBB University of Economics and Technology
1 shared publication - Ersin Emre Oren
Bionanodesign Laboratory, Department of Biomedical Engineering, TOBB University of Economics and Technology, Ankara, Turkey
1 shared publication - Joshua Hihath
Center for Bioelectronics and Biosensors School of Electrical, Computer, and Energy Engineering Arizona State University Tempe Arizona 85287 USA
1 shared publication - Manjeri P. Anantram
Department of Electrical and Computer Engineering, University of Washington, Seattle, WA 98195, USA
1 shared publication - Mashari Alangari
Department of Electrical Engineering, University of Hail, 55476, Hail, Saudi Arabia.
1 shared publication
Latest Publications
- Open Access
- 2 February 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Identifying SARS-CoV-2 Variants using Single-Molecule Conductance Measurements
The global COVID-19 pandemic has highlighted the need for rapid, reliable, and efficient detection of biological agents and the necessity of tracking changes in genetic material as new SARS-CoV-2 variants emerge. Here we demonstrate that RNA-based, single-molecule conductance experiments can be used to identify specific variants of SARS-CoV-2. To this end, we i) select target sequences of interest for specific variants, ii) utilize single-molecule break junction measurements to obtain conductance histograms for each sequence and its potential mutations, and iii) employ the XGBoost machine learning classifier to rapidly identify the presence of target molecules in solution with a limited number of conductance traces. This approach allows high specificity and high-sensitivity detection of RNA target sequences less than 20 base pairs in length by utilizing a complementary DNA probe capable of binding to the specific target. We use this approach to directly detect SARS-CoV-2 variants of concerns B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617.2 (Delta), and B.1.1.529 (Omicron) and further demonstrate that the specific sequence conductance is sensitive to nucleotide mismatches, thus broadening the identification capabilities of the system. Thus, our experimental methodology detects specific SARS CoV-2 variants, as well as recognizes the emergence of new variants as they arise.
- 2 February 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessIdentifying SARS-CoV-2 Variants using Single-Molecule Conductance Measurements
The global COVID-19 pandemic has highlighted the need for rapid, reliable, and efficient detection of biological agents and the necessity of tracking changes in genetic material as new SARS-CoV-2 variants emerge. Here we demonstrate that RNA-based, single-molecule conductance experiments can be used to identify specific variants of SARS-CoV-2. To this end, we i) select target sequences of interest for specific variants, ii) utilize single-molecule break junction measurements to obtain conductance histograms for each sequence and its potential mutations, and iii) employ the XGBoost machine learning classifier to rapidly identify the presence of target molecules in solution with a limited number of conductance traces. This approach allows high specificity and high-sensitivity detection of RNA target sequences less than 20 base pairs in length by utilizing a complementary DNA probe capable of binding to the specific target. We use this approach to directly detect SARS-CoV-2 variants of concerns B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617.2 (Delta), and B.1.1.529 (Omicron) and further demonstrate that the specific sequence conductance is sensitive to nucleotide mismatches, thus broadening the identification capabilities of the system. Thus, our experimental methodology detects specific SARS CoV-2 variants, as well as recognizes the emergence of new variants as they arise.